Volume 18, Number 4—April 2012
CME ACTIVITY - Research
Influenza-associated Hospitalizations by Industry, 2009–10 Influenza Season, United States
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: March 14, 2012; Expiration date: March 14, 2013
Upon completion of this activity, participants will be able to:
• Distinguish the effect of employment on the risk for hospitalization for influenza
• Assess the risk for hospitalization for influenza across different sectors of industry
• Evaluate the interaction between underlying medical illness and the risk for hospitalization for influenza among workers
• Analyze other factors potentially associated with the risk for hospitalization for influenza among workers.
Thomas J. Gryczan, MS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Thomas J. Gryczan, MS, has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Sara E. Luckhaupt, MD, MPH; Mackenzie Nowell, MPH; Tiffany D’Mello, MPH; Arthur Reingold, MD; James Meek, MPH; Kimberly Yousey-Hindes; Renee Funk, DVM; Patricia Ryan, MS; Ruth Lynfield, MD; Craig Morin, MPH; Joan Baumbach, MD, MPH; Shelley Zansky, PhD; Nancy M. Bennett, MD, MS; Ann Thomas, MD, MPH; and Timothy Jones, MD, have disclosed no relevant financial relationships. Marie Haring Sweeney, PhD, MPH, has disclosed the following relevant financial relationships: owns stock, stock options, or bonds from P&G, Apple, Lucent, J&J. Geoffrey M. Calvert, MD, MPH, has disclosed the following relevant financial relationships: owns stock, stock options, or bonds from Bristol-Myers Squibb, Abbott, Amgen, Baxter, Gen-Probe, Johnson & Johnson, Pfizer, Gilead, St. Jude Medical, Stryker, Teva, Novartis. Kathryn E. Arnold, MD, has disclosed the following relevant financial relationships: owns stock, stock options, or bonds from Steris Corp, Kimberley Clark Corp. William Schaffner, MD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Merck, sanofi-Pasteur, Pfizer, GSK, Dynavax.
- Page created: March 15, 2012
- Page last updated: May 02, 2012
- Page last reviewed: May 02, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)